More links surface between bankruptcy case under FBI investigation and church reorganization Some in church case worry whether connections mean they are getting a ‘fair shake’ The Guardian - US · Dec 20, 2024
Expert issues report on how to settle highly contentious New Orleans church bankruptcy case Mohsin ‘Mo’ Meghji was paid $350,000 to advise on conflicting settlement proposals from the church and clergy abuse victims The Guardian - US · Oct 24, 2024
Expert hired to help resolve New Orleans archdiocese bankruptcy faces FBI scrutiny Mohsin Meghji’s conduct in a separate case raised ethics questions as ex-judge he was linked to faces investigation The Guardian - US · Oct 11, 2024
New Orleans archdiocese bankruptcy parties wary of turnaround expert after WSJ investigation Mohsin Meghji drew scrutiny for behavior with bankruptcy judges in unrelated case involving drugmaker The Guardian - US · Oct 6, 2024
Super Bowl lesson: Starting on defense can give you an advantage In this informative article, we explore the lessons learned from the overtime coin toss in Super Bowl LVIII and how they can be applied in negotiations and... Top News · Feb 12, 2024
David Goodwillie vows to ‘speak my truth’ after third club cancel contract following fans backlash Australian second-tier side FC Sorrento announced on Wednesday that they had recruited the 34-year-old. The Independent UK · Jun 29, 2023
David Goodwillie vows to ‘speak my truth’ after another club cancels his deal Australian second-tier side FC Sorrento announced on Wednesday that they had recruited the 34-year-old. The Independent UK · Jun 28, 2023
David Goodwillie has contract cancelled in Australia after backlash The 34-year-old was ruled by a judge at a civil court case in 2017 to have raped a woman in 2011. The Independent UK · Jun 28, 2023
Australian club pull plug on David Goodwillie signing hours after announcement Australian club Sorrento FC have rescinded a contract offered to David Goodwillie hours after announcing he had been signed. The National (Scotland) · Jun 28, 2023
B&M launches huge Easter sale with up to £100 off select garden furniture Shoppers can bag a deal just in time for the turn of the warmer weather, but they'll have to be quick! Chronicle Live · Apr 6, 2023
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Merck's (NYSE:MRK) lead asset MK-2060 for the reduction in risk of major thrombotic cardiovascular events in patients with end-stage renal disease (ESRD). Merck shares traded in a range of $89.72 to $90.97 on day volume of 5.2… Benzinga · Aug 23, 2022
FDA Gives Green Signal To Human Trial For Sorrento's STI-9167 Against Omicron The FDA has cleared Sorrento Therapeutics Inc's (NASDAQ:SRNE) investigational new drug application (IND) for intravenous (IV) STI-9167 (COVISHIELD) to study the safety and pharmacokinetics in healthy volunteers. STI-9167 is the IV formulation of the intranasal STI-9199 neutralizing antibody. Also Read: Sorrento To Start Late-Stage Trial Of Abivertinib In Critically-Ill COVID-19 Patients. The Phase 1 study… Benzinga · Apr 25, 2022
Sorrento To Start Late-Stage Trial Of Abivertinib In Critically-Ill COVID-19 Patients The FDA has signed off Sorrento Therapeutics Inc's (NASDAQ:SRNE) Phase 3 trial of abivertinib in severe COVID-19 patients. The clinical trial will be conducted in 2 phases, and the initial run-in will define the recommended Phase 3 Dose. In October last year, Sorrento released preliminary results of two phase 2 studies that seemed to show… Benzinga · Mar 31, 2022
Sorrento's Chimeric mRNA COVID-19 Vaccine Candidate Shows Preclinical Action Against Omicron Variants Sorrento Therapeutics Inc (NASDAQ:SRNE) announced the publication of a preprint entitled "Chimeric mRNA based COVID-19 vaccine induces protective immunity against Omicron and Delta." Serum collected from omicron-specific mRNA vaccine immunized animals provided superior protection against the infection of omicron strain, including the BA.1, BA.1+R346K, and the more recent BA.2 sublineage. The data demonstrated… Benzinga · Mar 21, 2022
Benzinga · Jan 21, 2022 The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective Here's a roundup of top developments in the biotech space over the last 24 hours.
Benzinga · Jan 20, 2022 Sorrento Therapeutics' COVID-19 Antibody Works Against Omicron Variant Sorrento Therapeutics Inc (NASDAQ: SRNE) has